Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Moves Up 37 Points. More details...
CBT 200 Closes With Small Gain. More details...
CBT 200 Takes A Hit. More details...
Company Will Seek Co-Promotion Deal For Hospitals. More...
CBT 200 Sinks 16 Points Lower. More details...
CBT 200 Takes A Tumble. More details...
The CBT 200 Gets Hosed. More details...
Journal Reports Allege Disease Mongering. More details...
Stocks Are Underperforming But Cause Is Hard To Find....
Medical Device Company Focuses On Stroke. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
